This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:



Study: BMAL1 modulates senescence programming via AP-1

BMAL1 modulates senescence programming via AP-1
BMAL1 contributes to AP-1 mediated transcriptional control of the senescence program and confers resistance to apoptosis. Credit: Aging (2023). DOI: 10.18632/aging.205112

A new research paper titled "BMAL1 modulates senescence programming via AP-1" has been published in Aging.

Cellular senescence and circadian dysregulation are biological hallmarks of aging. Whether they are coordinately regulated has not been thoroughly studied. In this new study, researchers Sarah K. Jachim, Jian Zhong, Tamas Ordog, Jeong-Heon Lee, Aditya V. Bhagwate, Nagaswaroop Kengunte Nagaraj, Jennifer J. Westendorf, João F. Passos, Aleksey V. Matveyenko, and Nathan K. LeBrasseur from the Mayo Clinic in Rochester, Minnesota, hypothesized that BMAL1, a pioneer transcription factor and master regulator of the molecular circadian clock, plays a role in the senescence program.

The researchers write, "Here, we demonstrate BMAL1 is significantly upregulated in senescent cells and has altered rhythmicity compared to non-senescent cells."

Through BMAL1-ChIP-seq, they showed that BMAL1 is uniquely localized to genomic motifs associated with AP-1 in senescent cells. Integration of BMAL1-ChIP-seq data with RNA-seq data revealed that BMAL1 presence at AP-1 motifs is associated with active transcription. Finally, the researchers showed that BMAL1 contributes to AP-1 transcriptional control of key features of the senescence program, including altered regulation of cell survival pathways, and confers resistance to drug-induced apoptosis.

"Overall, these results highlight a previously unappreciated role of the core circadian clock component BMAL1 on the molecular phenotype of senescent cells," conclude the researchers.

More information: Sarah K. Jachim et al, BMAL1 modulates senescence programming via AP-1, Aging (2023). DOI: 10.18632/aging.205112

Provided by Impact Journals LLC
Citation: Study: BMAL1 modulates senescence programming via AP-1 (2023, October 16) retrieved 24 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Turning the molecular clock back on halts neuroblastoma tumor growth


Feedback to editors